Literature DB >> 9727383

Alport syndrome and thin glomerular basement membrane disease.

C E Kashtan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9727383     DOI： 10.1681/ASN.V991736

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  39 in total

1.  Genotype-phenotype correlation in X-linked Alport syndrome.

Authors:  Mir Reza Bekheirnia; Berenice Reed; Martin C Gregory; Kim McFann; Alireza Abdollah Shamshirsaz; Amirali Masoumi; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

2.  X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.

Authors:  Xue Jun Fu; Kandai Nozu; Aya Eguchi; Yoshimi Nozu; Naoya Morisada; Akemi Shono; Mariko Taniguchi-Ikeda; Yuko Shima; Koichi Nakanishi; Igor Vorechovsky; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-11-18       Impact factor: 2.801

3.  Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion.

Authors:  Malin Sund; Yohei Maeshima; Raghu Kalluri
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

Review 4.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

5.  Ocular manifestations of Alport syndrome.

Authors:  Jian-Min Xu; Shi-Sheng Zhang; Qiong Zhang; Ying-Ming Zhou; Cai-Hong Zhu; Jian Ge; Ling Wang
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

6.  Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.

Authors:  Tomoko Horinouchi; Kandai Nozu; Tomohiko Yamamura; Shogo Minamikawa; Takashi Omori; Keita Nakanishi; Junya Fujimura; Akira Ashida; Mineaki Kitamura; Mitsuhiro Kawano; Wataru Shimabukuro; Chizuko Kitabayashi; Aya Imafuku; Keiichi Tamagaki; Koichi Kamei; Kenjirou Okamoto; Shuichiro Fujinaga; Masafumi Oka; Toru Igarashi; Akinori Miyazono; Emi Sawanobori; Rika Fujimaru; Koichi Nakanishi; Yuko Shima; Masafumi Matsuo; Ming Juan Ye; Yoshimi Nozu; Naoya Morisada; Hiroshi Kaito; Kazumoto Iijima
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

7.  Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.

Authors:  Malin Sund; Yuki Hamano; Hikaru Sugimoto; Akulapalli Sudhakar; Mary Soubasakos; Udaya Yerramalla; Laura E Benjamin; Jack Lawler; Mark Kieran; Amish Shah; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 8.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

9.  Development of kidney glomerular endothelial cells and their role in basement membrane assembly.

Authors:  Dale R Abrahamson
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

10.  Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.

Authors:  Yuki Hamano; Michael Zeisberg; Hikaru Sugimoto; Julie C Lively; Yohei Maeshima; Changqing Yang; Richard O Hynes; Zena Werb; Akulapalli Sudhakar; Raghu Kalluri
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.